BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18024411)

  • 1. Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation.
    Matsuda K; Nakazawa Y; Sakashita K; Shiohara M; Yamauchi K; Koike K
    Haematologica; 2007 Nov; 92(11):1576-8. PubMed ID: 18024411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.
    De Filippi P; Zecca M; Lisini D; Rosti V; Cagioni C; Carlo-Stella C; Radi O; Veggiotti P; Mastronuzzi A; Acquaviva A; D'Ambrosio A; Locatelli F; Danesino C
    Br J Haematol; 2009 Dec; 147(5):706-9. PubMed ID: 19775298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous remission of juvenile myelomonocytic leukemia with NRAS mutation.
    Alsultan A; Khalifah M; Alrabiaah AA
    Pediatr Hematol Oncol; 2012 Oct; 29(7):624-6. PubMed ID: 22857389
    [No Abstract]   [Full Text] [Related]  

  • 4. The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia.
    De Filippi P; Zecca M; Novara F; Lisini D; Maserati E; Pasquali F; Rosti V; Carlo-Stella C; Zavras N; Cagioni C; Zuffardi O; Pagliara D; Danesino C; Locatelli F
    Pediatr Blood Cancer; 2012 Sep; 59(3):580-2. PubMed ID: 22183880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation.
    Imamura M; Imai C; Takachi T; Nemoto T; Tanaka A; Uchiyama M
    Pediatr Blood Cancer; 2008 Oct; 51(4):569. PubMed ID: 18561174
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.
    Matsuda K; Sakashita K; Taira C; Tanaka-Yanagisawa M; Yanagisawa R; Shiohara M; Kanegane H; Hasegawa D; Kawasaki K; Endo M; Yajima S; Sasaki S; Kato K; Koike K; Kikuchi A; Ogawa A; Watanabe A; Sotomatsu M; Nonoyama S; Koike K
    Br J Haematol; 2010 Feb; 148(4):593-9. PubMed ID: 19874312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytosis associated with leukemia: a striking association with juvenile myelomonocytic leukemia.
    Unal S; Cetin M; Kutlay NY; Elmas SA; Gumruk F; Tukun A; Tuncer M; Gurgey A
    Ann Hematol; 2010 Apr; 89(4):359-64. PubMed ID: 19798502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
    Sugimoto Y; Muramatsu H; Makishima H; Prince C; Jankowska AM; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP
    Br J Haematol; 2010 Jul; 150(1):83-7. PubMed ID: 20408841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience.
    Hamdy N; Bokhary H; Elsayed A; Hozayn W; Soliman S; Salem S; Alsheshtawi K; Abdalla A; Hafez H; Hammad M
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e368-e374. PubMed ID: 32209330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biology of juvenile myelomonocytic leukemia (JMML)].
    Manabe A
    Rinsho Ketsueki; 2010 Jul; 51(7):526-31. PubMed ID: 20693772
    [No Abstract]   [Full Text] [Related]  

  • 11. Constitutional NRAS mutations are rare among patients with Noonan syndrome or juvenile myelomonocytic leukemia.
    Kraoua L; Journel H; Bonnet P; Amiel J; Pouvreau N; Baumann C; Verloes A; Cavé H
    Am J Med Genet A; 2012 Oct; 158A(10):2407-11. PubMed ID: 22887781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
    Manabe A
    Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].
    Koike K; Matsuda K
    Rinsho Ketsueki; 2013 Jun; 54(6):538-44. PubMed ID: 23823092
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.
    Tanaka M; Takahashi Y; Xu Y; Yoshida N; Yoshimi A; Villalobos IB; Hama A; Nishio N; Hidaka H; Wang Y; Yagasaki H; Kojima S
    Leuk Res; 2008 Jul; 32(7):1036-42. PubMed ID: 18164384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive transformation of juvenile myelomonocytic leukemia associated with duplication of oncogenic KRAS due to acquired uniparental disomy.
    Kato M; Yasui N; Seki M; Kishimoto H; Sato-Otsubo A; Hasegawa D; Kiyokawa N; Hanada R; Ogawa S; Manabe A; Takita J; Koh K
    J Pediatr; 2013 Jun; 162(6):1285-8, 1288.e1. PubMed ID: 23403250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
    Koike K; Matsuda K
    Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
    Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
    Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
    Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
    Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation.
    Maschan M; Bobrynina V; Khachatryan L; Kalinina I; Solopova G; Avdonin P; Nasedkina T; Novichkova G; Maschan A
    Pediatr Blood Cancer; 2014 Oct; 61(10):1871-3. PubMed ID: 24590757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of SIPA1 in patients with juvenile myelomonocytic leukemia.
    Yoshida N; Yagasaki H; Takahashi Y; Kudo K; Manabe A; Kojima S
    Br J Haematol; 2008 Sep; 142(5):850-1. PubMed ID: 18492118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.